I haven’t sold a share. I won’t sell a share. There is
I haven’t sold a share. I won’t sell a share. There is no need to sell a share. The share price will come back. Some will lose and some who stay will win in the end. Why... because some will believe in the science. That’s the bottom line. We all have ran the numbers here on the board and we know that the overall percentages and they show a home run. You know it... I know it... and now the FDA and other agencies know it.
Hence the reason to negotiate. What would we negotiate? There are a few things we should negotiate. If I am Cytodyn I would negotiate after seeing what kind of help the FDA is offering. Fast tracked production facilities other than what we have already? Help with down payments on manufacturing? Help with a great PR so the Doctors in our country and the world know what all should know. For these items to help progress our manufacturing. We negotiate in good faith what the FDA seeks in volume and price commitments.
Does anyone see it any different? What else is there to negotiate. EUA is a given what we already know and the FDA also knows this. Otherwise we wouldn’t be in negotiations at all. So we either negotiate a deal with the FDA or we move on to other markets and the FDA knows this since we let out a PR today to inform them yet again that they are not the only game in town and we will sell our inventory to whomever negotiates the best deal or offers the most help. Fact is we will probably have the Philippines buying their 100,000 promised doses first before any other deals and that will fund some manufacturing. The Philippines just wanted the mortality and that only took minutes to do that math. If I am Nader I am leaning back in the biggest chair in the room and chewing on a cigar flicking a lighter with the threat of lighting it at any moment but not lighting it because he knows deep down he is holding the best hand possible and his cell phone won’t stop ringing and he keeps the attention of the FDA by saying “ damn... that is the MHRA again” then the next ring damn that’s Health Canada yet again. Then smugly asking ... so what are you thinking? How can you help us?
So when you look at the big picture in a negotiation way. The FDA doesn’t hold the best hand and they know it. Hence asking for confidential negotiations to keep Janet Woodcock in the running for full time FDA commissioner. As for confidential negotiations... you know this isn’t something that Nader would of suggested. He would be crowing from the tallest building in Vancouver Washington. Telling the world what we have.
This is my opinion on how the day has progressed. I hope it’s somewhere close to what I have said. I may be way off but one thing I do know is the science supports what we all know. That the efficacy of the trial is probably even better that what everyone thought except me. Ask your self why is there secrecy at all if the FDA isn’t worried they can’t strike a deal? Every vaccine company has announced preliminary results in the past. Even before making a deal. Every other therapeutic has fallen with no results in Severe to Critical and announced even before all data was announced and most even after getting to a mid trial analysis.
What we know is we are ready and everyone wants a piece of our pie... there will be no cake served here...
5
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
When Water Becomes Front Page News You'd think something as basic as water wouldn't need much chatter. Yet, when the taps go dry, people panic like there's no tomorrow. American Water (NYSE: AWK) is looking to keep that at bay, with their latest tips on staying ahead of any potential water service hiccups. Let's be real: their service underpins everything, from your...
Continue Reading
Revolutionizing Cancer Treatment: Immunofoco's Approach In the battle against B-cell malignancies, the old ways of doing things sometimes just don’t cut it, folks. Enter Immunofoco. At the recent Society for Immunotherapy of Cancer (SITC) 2026 meeting, they laid some ambitious cards on the table with their in vivo T-cell engager (TCE) delivery strategy. Engineering...
Continue Reading
CRET Broadens the Path to Fixed-Income Security If you're the type who gets a rash just thinking about stock market jitters, pay attention: Compound Real Estate Bonds (CREB) has cracked the door open a bit wider for your retirement peace of mind. They've teamed up with Equity Trust to offer their rock-solid 8.50% APY bonds through self-directed IRAs. That's right—these...
Continue Reading
Munters' Bold New Targets and Strategic Moves Ever feel like you're on a constant treadmill chasing numbers? Munters Group knows the feeling. Over in Stockholm, they've just laid out fresh strategies at their Capital Markets Day—not just any pie-in-the-sky type goals, but heavy hitters that are setting the tone for their future. CEO Stefan Aspman is all geared up,...
Continue Reading
Oxford Computer Group Strikes Again Another day, another nod from the big boys at Microsoft, eh? Oxford Computer Group, now part of MajorKey Technologies, hasn't just found themselves in the mix—they're standing tall as a finalist for not one but two significant categories in the 2026 Microsoft Partner of the Year Awards: Secure Access and Defense and Intelligence. You...
Continue Reading
An Unfolding Legal Drama for Gildan Alright, folks, it's time to dissect what's going on with Gildan Activewear, where things have taken a hard left turn into legal chaos. A class action lawsuit is shaking up the table, and let me tell you, it's got more layers than an onion. The case hinges on allegations that the company pulled a fast one with its financial controls,...
Continue Reading
Allegations at the Heart of the Matter When school administrators turn a blind eye to student safety, there's bound to be fallout. Jaclyn Schwieger, a former coach at Latin School of Chicago, has hit back with a federal lawsuit. She claims her concerns about questionable behavior by male volleyball coaches were met with reprisal rather than resolution. Now she's taking...
Continue Reading
Steady Ship in Turbulent Waters First International Bank of Israel (TASE: FIBI) isn't just another banking group to keep under your pillow. This quarter, they've dropped some numbers that'll make investors sit up straight. Their Q3 results show they're navigating through the rough seas of macroeconomic upheavals and gnarly tax hurdles with resilience and clarity....
Continue Reading
PU200's Debut: Making Safety and Space Work in Tandem Ever noticed how safety's become the name of the game for data center operations? Powered by the influx of AI, these digital fortresses crave robust power backup, and Ampace’s stepping in with their PU200 UPS battery solution at Data Centre World Paris 2026. Showing off at Hall 5, Booth M65, Ampace's bringing to the...
Continue Reading
Baijiu Brews Cultural Ties at Melbourne Cup If you thought the Melbourne Cup was only about horse racing, think again. This year, the carnival wasn’t just a playground for the equestrian elite but also a stage for cultural exchange, and Chinese baijiu had its moment to shine. It’s not just about sipping a strong spirit; it's about bridging cultures and building...
Continue Reading
Top 5 Most Recently Viewed Articles
Nimbus Meals: A New Approach to GLP-1 Therapy Nimbus Healthcare has partnered with Snap Kitchen to unveil a groundbreaking initiative called Nimbus Meals. This program is designed to integrate GLP-1 therapy with nutritionally tailored meals, aiming to support individuals in achieving sustainable metabolic health. This innovative approach makes it easier for patients to...
Continue Reading
Endeavour Mining Addresses Concerns from Recent Media Reports Endeavour Mining plc (LSE:EDV, TSX:EDV, OTCQX:EDVMF) has recently made headlines following media reactions to remarks from the President of Burkina Faso, Ibrahim Traoré. These comments emerged shortly after a radio interview where President Traoré discussed various national issues, including security and...
Continue Reading
GITAI USA Inc. (GITAI) isn’t just making waves; it's revolutionizing the space robotics game. The company has recently announced a significant expansion of its headquarters that’s set to propel it forward in this rapidly evolving industry. Now, hold onto your helmets—this new facility is over four times larger than the old one, which means more room for...
Continue Reading
Human-I-T Wins the Coveted BigCommerce Innovation Award Human-I-T has received the 2024 BigCommerce Innovation Award, which highlights its remarkable efforts in fostering digital inclusion and aiding underserved communities. This honor acknowledges the nonprofit’s dedication to delivering essential technology resources, internet access, and digital education to those...
Continue Reading
Biosynth Biological Technology Opens Its Doors in Suzhou Biosynth, a prominent developer and supplier of essential raw materials and services for the diagnostics, vaccines, and pharmaceutical industries, is proud to announce the opening of its new facility, Biosynth Biological Technology, located in Lifebay, Suzhou, China. This cutting-edge site features state-of-the-art...
Continue Reading